Portfolio company Oxa raises $103m in Series D
Summary by AI BETAClose X
|
FOR RELEASE ON |
04 March 2026
|
Portfolio company Oxa raises $103m in Series D first close, backed by National Wealth Fund and leading investors
IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which invests in breakthrough science and technology companies with the potential to create a better future for all, notes that portfolio company Oxa Autonomy Ltd ("Oxa" or "the Company") has announced the successful first close of its Series D funding round, raising a total of $103m.
Oxa, a global leader in autonomous vehicle technology, noted an initial $50m commitment from the National Wealth Fund, alongside backing from NVentures (NVIDIA's venture capital arm) and additional capital from existing shareholders IP Group and its Hostplus managed funds, and bp Ventures completed the first close. The investment will enable Oxa to intensify its focus on commercialising solutions for Industrial Mobility Automation (IMA), which involves the automation of repetitive industrial driving tasks.
IP Group invested £7.5m ($10m) from its balance sheet to the financing round and £19m ($25m) from its Hostplus managed funds*. Following completion, IP Group has an undiluted beneficial holding of 10.6% in Oxa, with a further 9.7% held via its managed funds.
Greg Smith, Chief Executive of IP Group, said: "This funding round - with backing from the National Wealth Fund and NVentures (NVIDIA's venture capital arm) - underlines the growing conviction behind Oxa's leadership in Industrial Mobility Automation. We believe Oxa's 'universal AI driver' approach positions it to scale autonomy across industrial vehicles and environments as adoption accelerates. For shareholders, IP Group offers a differentiated route to exposure to a leading private AI company in mobile autonomy."
*Includes funds managed/advised on behalf of Hostplus.
For more information, please contact:
|
IP Group plc |
www.ipgroupplc.com |
|
Liz Vaughan-Adams, Communications |
+44 (0) 20 7444 0062/+44 (0) 7967 312125 |
|
Portland |
|
|
Lewis Bendall-Craft |
+44 (0) 7931 973950 |
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science and technology investor, we develop and support some of the world's most exciting businesses in healthtech, deeptech and cleantech. Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 11 hours ago Luceco
- 12 hours ago Helios Towers
- 12 hours ago Wise Class A
- 12 hours ago EDX Medical Group Plc
- 12 hours ago Naked Wines